Nearly twenty years after their entry into the capital, Sofipaca and Région Sud Investissement renew their confidence in Provepharm by reinjecting funds into the holding company of the co-founders, Michel Féraud and Christophe Baralotto....
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Nearly twenty years after their entry into the capital, Sofipaca and Région Sud Investissement renew their confidence in Provepharm by reinjecting funds into the holding company of the co-founders, Michel Féraud and Christophe Baralotto....